Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / HALO - Halozyme Therapeutics Inc. (HALO) CEO Helen Torley on Q1 2022 Results - Earnings Call Transcript

HALO - Halozyme Therapeutics Inc. (HALO) CEO Helen Torley on Q1 2022 Results - Earnings Call Transcript

Halozyme Therapeutics Inc.
Halozyme Therapeutics, Inc. (HALO) Q1 2022 Earnings Conference Call May 10, 2022 04:30 PM ET Company Participants Helen Torley - President & Chief Executive Officer Nicole LaBrosse - Chief Financial Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Mike DiFiore - Evercore Corinne Jenkins - Goldman Sachs Jessica Fye - JPM Chase Anita Dushyanth - Berenberg Capital Markets Presentation Operator Good afternoon. My name is Emma, and I will be your conference operator today. At this time, I would like to welcome everyone to the Halozyme First Quarter 2022 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. Don Sharlene [ph], you may begin your conference. Unidentified Company Representative Good afternoon, and welcome to our first quarter 2022 financial results conference call. In addition to our press release

For further details see:

Halozyme Therapeutics, Inc. (HALO) CEO Helen Torley on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Halozyme Therapeutics Inc.
Stock Symbol: HALO
Market: NASDAQ
Website: halozyme.com
Menu
HALO HALO Quote HALO Short HALO News HALO Articles HALO Message Board
Get HALO Alerts

News, Short Squeeze, Breakout and More Instantly...